PMC:7170415 / 11243-12572 JSONTXT 6 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T84 0-205 Sentence denotes In response to the rapidly evolving COVID-19 pandemic, countries have used different testing approaches depending on testing capacity, public health resources, and the spread of the virus in the community.
T85 206-382 Sentence denotes In the United States, diagnostic testing indications and capacity were limited at the beginning of the outbreak, largely because of regulatory hurdles for the use of new tests.
T86 383-519 Sentence denotes To expand access to testing, the FDA released policies to allow laboratories to use their validated assays in a more timely manner (27).
T87 520-724 Sentence denotes On 4 March, the Centers for Disease Control and Prevention (CDC) removed restrictive testing criteria, recommending that clinicians use their judgment to determine whether a test should be performed (28).
T88 725-837 Sentence denotes Because testing capacity remains suboptimal (27), the implementation of this recommendation remains a challenge.
T89 838-1183 Sentence denotes The CDC still recommends priority for testing 3 groups: hospitalized patients with presentations compatible with COVID-19, other symptomatic persons at risk for poor outcomes, and persons who had close contact with someone with suspected or confirmed COVID-19 within 14 days of illness onset or have a history of travel in an affected area (28).
T90 1184-1272 Sentence denotes These patients should be evaluated with a molecular diagnostic test, as described later.
T91 1273-1329 Sentence denotes The CDC does not recommend testing asymptomatic persons.